Search research articles
Contact Us
Filters
Showing results (121-130 of 190) with videos related to
Page
of 19
Sort By:
Clinical Science (London, England : 1979)
|
May 19, 2016
Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice
Elyse Di Marco, Stephen P Gray, Phyllis Chew, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 3, 2020
Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy
Devy Deliyanti, Saeed F Alrashdi, Rhian M Touyz, et al.
Kidney International
|
August 18, 2019
Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease
Lois A Balmer, Rhiannon Whiting, Caroline Rudnicka, et al.
Clinical Science (London, England : 1979)
|
January 20, 2022
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease
Jakob A Østergaard, Jay C Jha, Arpeeta Sharma, et al.
Circulation Research
|
January 11, 2000
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition
K Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.
Journal of the American Society of Nephrology : JASN
|
August 19, 2005
Interactions between renin angiotensin system and advanced glycation in the kidney
Merlin C Thomas, Christos Tikellis, Wendy M Burns, et al.
Atherosclerosis
|
December 21, 2007
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
C Tikellis, K A Jandeleit-Dahm, K Sheehy, et al.
Journal of Cellular and Molecular Medicine
|
September 17, 2009
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo
Mandy L Ballinger, Narin Osman, Kazuhiko Hashimura, et al.
Circulation
|
July 10, 2002
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice
Riccardo Candido, Karin A Jandeleit-Dahm, Zemin Cao, et al.
Diabetologia
|
October 29, 2009
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
A M D Watson, J Li, C Schumacher, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 190) with videos related to
Sort By:
Page
of 19
Clinical Science (London, England : 1979)
|
May 19, 2016
Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice
Elyse Di Marco, Stephen P Gray, Phyllis Chew, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 3, 2020
Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy
Devy Deliyanti, Saeed F Alrashdi, Rhian M Touyz, et al.
Kidney International
|
August 18, 2019
Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease
Lois A Balmer, Rhiannon Whiting, Caroline Rudnicka, et al.
Clinical Science (London, England : 1979)
|
January 20, 2022
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease
Jakob A Østergaard, Jay C Jha, Arpeeta Sharma, et al.
Circulation Research
|
January 11, 2000
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition
K Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.
Journal of the American Society of Nephrology : JASN
|
August 19, 2005
Interactions between renin angiotensin system and advanced glycation in the kidney
Merlin C Thomas, Christos Tikellis, Wendy M Burns, et al.
Atherosclerosis
|
December 21, 2007
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
C Tikellis, K A Jandeleit-Dahm, K Sheehy, et al.
Journal of Cellular and Molecular Medicine
|
September 17, 2009
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo
Mandy L Ballinger, Narin Osman, Kazuhiko Hashimura, et al.
Circulation
|
July 10, 2002
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice
Riccardo Candido, Karin A Jandeleit-Dahm, Zemin Cao, et al.
Diabetologia
|
October 29, 2009
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
A M D Watson, J Li, C Schumacher, et al.
Page
of 19